Thank you for your interest in applying to become a Discseel^® providing physician.

The Discseel^® Procedure provides high safety and efficacy for treating lumbar and cervical disc pathology when compared to other surgical and non-surgical treatments and is being performed more frequently by spine surgeons in the United States, Europe, and Asia. 

This procedure works by utilizing Fibrin, an FDA-approved substance that is used off-label, made by Baxter Pharmaceutical to first seal annular tears, then stimulate disc tissue growth, permanently repairing disc pathology.  A randomized, controlled study confirms the ability of Baxter’s Fibrin used off-label to regrow disc tissue and was awarded the NASS Outstanding Paper. Safety and efficacy profiles of the Discseel^® Procedure surpass all spine surgery study results.

If you believe you have the expertise to join our growing team of Discseel^® providers, please fill out the form below and we will reach out to you if we feel you are the right fit.